DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Tveit KM. et al.
Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study.
J Clin Oncol 2012;
30: 1755-1762
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.